Joanne E. Davis
Grattan St
Parkville, VIC 3050, Australia
Parkville, VIC 3050, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Post-transplant anti-thymocyte globulin exposure predicts graft-versus-host disease and donor chimerism outcomes in reduced intensity conditioning allogeneic stem cell transplantation.
Journal: Frontiers in immunology
Published: May 12, 2026
Identification of T:B Cell Multimers After Bispecific T Cell Engagement, Using Both Conventional and Imaging Flow Cytometry.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology
Published: March 13, 2026
Marginal zone lymphoma is associated with dysregulated T-cell immunity that is not altered by ibrutinib-venetoclax treatment.
Journal: Blood neoplasia
Published: February 13, 2026
Modified cell trace violet proliferation assay preserves lymphocyte viability and allows spectral flow cytometry analysis.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology
Published: October 10, 2023
A phase 1 dose-escalation study of low-dose lenalidomide maintenance post-allogeneic stem cell transplantation for high-risk acute myeloid leukaemia or myelodysplastic syndrome.
Journal: Bone marrow transplantation
Published: September 14, 2023
A phase 1 clinical trial of the repurposable acetyllysine mimetic, n-methyl-2-pyrrolidone (NMP), in relapsed or refractory multiple myeloma.
Journal: Clinical epigenetics
Published: September 25, 2022
Venetoclax or Ruxolitinib in Pre-Transplant Conditioning Lowers the Engraftment Barrier by Different Mechanisms in Allogeneic Stem Cell Transplant Recipients.
Journal: Frontiers in immunology
Published: July 29, 2021
Ibrutinib protects T cells in patients with CLL from proliferation-induced senescence.
Journal: Journal of translational medicine
Published: June 23, 2021
Who needs, receives and misses out on palliative and end-of-life care? A population-based study to identify needs and gaps in a regional health service.
Journal: Australian health review : a publication of the Australian Hospital Association
Published: February 16, 2021
Nivolumab induces dynamic alterations in CD8 T-cell function and TIM-3 expression when used to treat relapsed acute myeloid leukemia after allogeneic stem cell transplantation.
Journal: Leukemia & lymphoma
Published: August 08, 2019
Recipient BCL2 inhibition and NK cell ablation form part of a reduced intensity conditioning regime that improves allo-bone marrow transplantation outcomes.
Journal: Cell death and differentiation
Published: May 31, 2018
Last Updated: 09/26/2026